Psychedelic research continued at pace during the summer of 2021. New research focusing on the risks of psychedelics, the benefits when treating addictions, knowledge of different groups about psychedelics (and much more) was published. The transdiagnostic ability of psychedelics continues to be tested. The goal of RCTs is to control for factors that aren’t under direct experimental control.


Previous articleBetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders
Next articlePT264 – Gibrán Rivera – Group Process, Self-sovereignty, and Rethinking Masculinity